SCHEMBL2008998

SCHEMBL2008998

Nc1occ2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.42
HSD17B10 Q99714 6/20 0.42
HPGD P15428 4/20 0.42
TSHR P16473 3/20 0.42
CYP3A4 P08684 1/20 0.42
KEAP1 Q14145 1/20 0.42
TDP1 Q9NUW8 2/20 0.39
CYP2A6 P11509 2/20 0.39
F12 P00748 1/20 0.37
PLAU P00749 1/20 0.37
NCF1 P14598 1/20 0.37
NOS3 P29474 1/20 0.37
NOS1 P29475 1/20 0.37
NOS2 P35228 1/20 0.37
BACE1 P56817 1/20 0.37
HPRT1 P00492 2/20 0.36
KDM4E B2RXH2 4/20 0.36
GLA P06280 2/20 0.36
CASP1 P29466 2/20 0.36
CASP7 P55210 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9427742 0.70 MITF (0.44) ALDH1A1HSD17B10HPGDCYP3A4TDP1
SCHEMBL286416 0.70 ALDH1A1 (0.39) ALDH1A1HSD17B10HPGDTSHRCYP3A4
SCHEMBL1097671 0.70 CYP2A6 (0.42) ALDH1A1HSD17B10HPGDTSHRCYP3A4
SCHEMBL2012336 0.70 ALDH1A1 (0.39) ALDH1A1HSD17B10HPGDTSHRCYP3A4
SCHEMBL4079696 0.70 CYP2A6 (0.42) ALDH1A1HSD17B10HPGDTSHRCYP3A4
SCHEMBL4897405 0.70 ALDH1A1 (0.39) ALDH1A1HSD17B10HPGDTSHRCYP3A4
SCHEMBL276956 0.70 ALDH1A1 (0.39) ALDH1A1HSD17B10HPGDTSHRTDP1
SCHEMBL1605255 0.70 ALDH1A1 (0.39) ALDH1A1HSD17B10HPGDTSHRCYP3A4
SCHEMBL21179481 0.70 ALDH1A1 (0.39) ALDH1A1HSD17B10HPGDTSHRCYP3A4
SCHEMBL2488251 0.70 ALDH1A1 (0.39) ALDH1A1HSD17B10HPGDTSHRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114026199-B Polarized light emitting film, polarized light emitting panel and display device containing water-soluble coumarin compound or salt thereof 日本化药株式会社 2023-12-26 CN disclosed
CN-110945083-B Styrene compound or salt thereof, polarizing film, polarizing plate and display device 日本化药株式会社 2022-07-01 CN disclosed
CN-114026199-A Polarizing luminescent film, polarizing luminescent sheet, and display device containing water-soluble coumarin compound or salt thereof 日本化药株式会社 2022-02-08 CN disclosed
CN-110945083-A Styrene compound or salt thereof, polarizing film, polarizing plate and display device 日本化药株式会社 2020-03-31 CN disclosed
CN-105377863-B polycyclic compounds 默克专利有限公司 2019-03-01 CN disclosed
US-10205106-B2 Polycyclic compounds MERCK PATENT GMBH (DE) 2019-02-12 US disclosed
EP-3016959-B1 POLYCYCLIC COMPOUNDS MERCK PATENT GMBH (DE) 2017-12-27 EP disclosed
CN-104478875-B Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) 麦迪韦逊科技有限公司 2017-04-12 CN disclosed
US-20160204358-A1 POLYCYCLIC COMPOUNDS MERCK PATENT GMBH (DE) 2016-07-14 US disclosed
EP-3016959-A1 POLYCYCLIC COMPOUNDS Merck Patent GmbH (DE) 2016-05-11 EP disclosed
US-20080004262-A1 Tricyclic Benzopyrane Compound as Anti-Arrhythmic Agents NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2008-01-03 US disclosed
CN-1934116-A Tricyclic benzopyran compounds useful as antiarrhythmic agents NISSAN CHEMICAL IND LTD (JP) 2007-03-21 CN disclosed
EP-1732929-A1 TRICYCLIC BENZOPYRAN COMPOUND AS ANTI-ARRHYTHMIC AGENTS Nissan Chemical Industries, Ltd. (JP) 2006-12-20 EP disclosed
WO-2005090357-A1 TRICYCLIC BENZOPYRAN COMPOUND AS ANTI-ARRHYTHMIC AGENTS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2005-09-29 WO disclosed
US-6384065-B1 CONTROL THE FUNCTIONS OF PROTEINS SUCH AS ENZYMES AND RECEPTOR FORTREATING INFLAMMATORY DISEASES SUCH AS RHEUMATOID ARTHRITIS, TOYAMA CHEMICAL CO., LTD. (JP) 2002-05-07 US disclosed
CN-1141632-A 4-amino 6-substituted mycophenolic acid with immunosuppressive activity and derivatives thereof SYNTEX INC (US) 1997-01-29 CN disclosed
CN-1141039-A 4-amino derivatives of 5-substituted mycophenolic acid SYNTEX INC (US) 1997-01-22 CN disclosed
EP-0197657-B1 A NOVEL PROCESS FOR PREPARING AMIDES FROM NITRILES AND AMINES OSAKA UNIVERSITY (JP) 1991-02-27 EP disclosed
US-4942220-A METAL COORDINATION CATALYST OSAKA UNIVERSITY (JP) 1990-07-17 US disclosed
US-4801748-A METAL COMPLEX CATALYST OSAKA UNIVERSITY (JP) 1989-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160204358-A1 POLYCYCLIC COMPOUNDS VDAC2, VDAC3, KCNC1 ALDH1A1 2257/4885HSD17B10 3397/4885HPGD 2786/4885
US-20080004262-A1 Tricyclic Benzopyrane Compound as Anti-Arrhythmic Agents CBR1, CBR3, SCN8A ALDH1A1 2087/4885HSD17B10 1207/4885HPGD 2882/4885
US-10205106-B2 Polycyclic compounds VDAC2, VDAC3, KCNC1 ALDH1A1 2257/4885HSD17B10 3397/4885HPGD 2786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.